A prospective, randomized clinical trial of emergency treatment of chemotherapy-induced neutropenia and febrile neutropenia by pegylated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF).

Xiaofeng Huang, Shuo Li,Wenjie Shi,Ye Wang,Xinyu Wan,Jinzhi He,Yinggang Xu,Weiwei Zhang,Xiaoqing Shi,Rui Chen,Lu Xu,Xiaoming Zha,Jue Wang

British Journal of Clinical Pharmacology（2023）

引用 0|浏览10

暂无评分

摘要

This study supported that the PEG-rhG-CSF was more effective and convenient than rhG-CSF for treating grades 3-4 neutropenia and FN in patients with breast cancer and had manageable toxicity.

查看译文

关键词

PEG-rhG-CSF,breast cancer,febrile,neutropenia,rhG-CSF

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要